Jackson Square Partners LLC lessened its stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) by 14.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,627,513 shares of the company's stock after selling 277,982 shares during the quarter. Stevanato Group accounts for 3.8% of Jackson Square Partners LLC's investment portfolio, making the stock its 4th largest position. Jackson Square Partners LLC owned approximately 0.54% of Stevanato Group worth $35,464,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Pier Capital LLC grew its holdings in Stevanato Group by 2.9% in the fourth quarter. Pier Capital LLC now owns 381,624 shares of the company's stock valued at $8,316,000 after purchasing an additional 10,627 shares during the last quarter. Zions Bancorporation N.A. boosted its position in shares of Stevanato Group by 29.7% in the 4th quarter. Zions Bancorporation N.A. now owns 68,017 shares of the company's stock worth $1,482,000 after buying an additional 15,555 shares in the last quarter. Advantage Alpha Capital Partners LP grew its stake in Stevanato Group by 27.3% in the 4th quarter. Advantage Alpha Capital Partners LP now owns 293,865 shares of the company's stock valued at $6,403,000 after acquiring an additional 63,041 shares during the last quarter. LPL Financial LLC raised its position in Stevanato Group by 24.6% during the fourth quarter. LPL Financial LLC now owns 85,721 shares of the company's stock worth $1,940,000 after acquiring an additional 16,915 shares during the last quarter. Finally, Fox Run Management L.L.C. acquired a new stake in shares of Stevanato Group in the fourth quarter valued at approximately $317,000.
Stevanato Group Stock Performance
NYSE:STVN opened at €22.34 ($24.02) on Tuesday. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($17.81) and a fifty-two week high of €33.49 ($36.01). The firm's 50 day moving average is €21.04 and its two-hundred day moving average is €20.59. The company has a market cap of $6.77 billion, a P/E ratio of 47.53, a P/E/G ratio of 7.18 and a beta of 0.60. The company has a quick ratio of 1.21, a current ratio of 1.81 and a debt-to-equity ratio of 0.22.
Stevanato Group (NYSE:STVN - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The company reported €0.20 ($0.22) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of €0.20 ($0.22). The firm had revenue of €352.68 million during the quarter, compared to the consensus estimate of €346.26 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current year.
Analyst Upgrades and Downgrades
Several equities analysts have weighed in on the company. Morgan Stanley reissued an "equal weight" rating and set a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research report on Tuesday, December 3rd. UBS Group decreased their price target on shares of Stevanato Group from $24.00 to $23.50 and set a "neutral" rating on the stock in a research note on Friday, March 7th. Wolfe Research started coverage on shares of Stevanato Group in a research report on Friday, December 13th. They issued an "outperform" rating and a $28.00 price objective for the company. William Blair restated an "outperform" rating on shares of Stevanato Group in a research report on Friday, March 7th. Finally, Bank of America boosted their price target on Stevanato Group from $24.00 to $26.00 and gave the company a "buy" rating in a report on Friday, December 13th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of €27.75 ($29.84).
Check Out Our Latest Analysis on Stevanato Group
About Stevanato Group
(
Free Report)
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Stevanato Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stevanato Group wasn't on the list.
While Stevanato Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
